Company & Sponsor Intelligence
Asan Medical Center
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed2
Countries1
Therapeutic footprint
dementia_otherepilepsyparkinsons
Indexed studies
NCT05740423Standardization of Anti-Seizure Medications Withdrawals After Seizure Remission in Young Patients With Epilepsy
epilepsy · South KoreaUNKNOWN
epilepsy · South KoreaUNKNOWN
NCT02555774Efficacy of Cognitive Training in Subjective Memory Impairment
dementia_other · South KoreaNA
dementia_other · South KoreaNA
NCT00468078Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients
parkinsons · South KoreaPHASE3
parkinsons · South KoreaPHASE3
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →